Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Derma Sciences

This article was originally published in The Gray Sheet

Executive Summary

Letter of intent to acquire Genetic Laboratorires Wound Care for stock valued at $3.6 mil. is announced May 12. Under the terms of the deal, 0.7 shares of Derma Sciences common stock, which closed at 2-1/8 on May 11, would be exchanged for each of St. Paul-based Genetic Laboratories' 2.4 mil. outstanding shares. The companies expect to sign a definitive agreement by the end of May and close the deal by September....
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT010041

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel